Back to Journals » Open Access Journal of Clinical Trials » Volume 3
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,399 | Dovepress* | 9,399+ | 2,288 | 11,687 | |
Totals | 9,399 | 2,288 | 11,687 | ||
*Since 6 February 2011 +Since July 2016 |
View citations on Google Scholar